Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Chondrosarcoma is a rare bone cancer that causes tumors to grow in the cartilage of the pelvis, long bones, ribs, scapula, and vertebrae. Symptoms include swelling at the site of the tumor, pain, and decreased range of motion. There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.

Inhibrx, a clinical-stage biotechnology company, is dedicated to helping people with life-threatening conditions. They are developing a therapeutic option for chondrosarcoma called INBRX-109, which is currently in clinical trials.

Stay tuned to meet with Dr. Sant Chawla of Sarcoma Oncology Center to learn more, and speak with one patient who is a chondrosarcoma survivor. Speak to your doctor to learn if a clinical trial may be right for you.

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

We're going Behind the Mystery of two rare diseases: Castleman disease and chondrosarcoma.

Comments

comments